Table 2.

Follow-up in studies groups.

	Number of patients	Average follow-up time (months)	Number of patients with follow-up time over 18 months	The average number of cystoscopies during follow-up
Beta-lactams	83	24 [12–36]	63 [76%]	3 [2–6]
(i) Amoxicillin and clavulanic acid	12	25 [12–36]	8 [67%]	3 [2–6]
(ii) Cefuroxime	6	26 [12–36]	4 [67%]	2 [2–5]
(iii) Cephazolin	65	24 [12–36]	51 [78%]	3 [2–6]
Ciprofloxacin	40	24 [12–36]	26 [65%]	3 [2–6]
No antibiotics	76	24 [12–36]	53 [70%]	3 [2–6]